Back to Results
First PageMeta Content
Gastroenterology / Salicylic acids / Abdominal pain / Colitis / Management of ulcerative colitis / Ulcerative colitis / Mesalazine / Inflammatory bowel disease / 4-Aminosalicylic acid / Medicine / Health / Autoimmune diseases


Aliment Pharmacol Ther 2005; 21: 1111–doi: j02458.x Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients
Add to Reading List

Document Date: 2005-05-10 02:05:12


Open Document

File Size: 85,89 KB

Share Result on Facebook
UPDATE